The clinical features, diagnosis, and treatment of cognitive impairments in Parkinson's disease
The review presents the data of recent studies dealing with cognitive impairments (CI) in patients with Parkinson's disease (PD) and gives their characteristics and epidemiology, the specific features of the pathogenesis and clinical manifestations, as well as current methods for their diagnosi...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA-PRESS LLC
2017-03-01
|
| Series: | Неврология, нейропсихиатрия, психосоматика |
| Subjects: | |
| Online Access: | https://nnp.ima-press.net/nnp/article/view/706 |
| _version_ | 1797876427906875392 |
|---|---|
| author | G. N. Akhmadeeva R. V. Magzhanov G. N. Tayupova A. R. Baitimerov |
| author_facet | G. N. Akhmadeeva R. V. Magzhanov G. N. Tayupova A. R. Baitimerov |
| author_sort | G. N. Akhmadeeva |
| collection | DOAJ |
| description | The review presents the data of recent studies dealing with cognitive impairments (CI) in patients with Parkinson's disease (PD) and gives their characteristics and epidemiology, the specific features of the pathogenesis and clinical manifestations, as well as current methods for their diagnosis and treatment. Moderate CIs (MCIs) occur in 18.9–55% of patients with PD; the prevalence of dementia during a cross-sectional study approaches 30%. The 2007 Movement Disorder Society criteria and algorithm for the diagnosis of dementia in PD and the 2012 criteria and the algorithm for the diagnosis of MCIs allow one to maximally accurately identify these disorders. Only rivastigmine is now recognized as effective in treating CI in PD and recommended for use. Overall, therapies for CI in PD have been inadequately investigated, making it necessary to conduct further large-scale studies. |
| first_indexed | 2024-04-10T02:03:02Z |
| format | Article |
| id | doaj.art-66b39f5c55af46b8a178b63ad7aaffc3 |
| institution | Directory Open Access Journal |
| issn | 2074-2711 2310-1342 |
| language | Russian |
| last_indexed | 2024-04-10T02:03:02Z |
| publishDate | 2017-03-01 |
| publisher | IMA-PRESS LLC |
| record_format | Article |
| series | Неврология, нейропсихиатрия, психосоматика |
| spelling | doaj.art-66b39f5c55af46b8a178b63ad7aaffc32023-03-13T08:42:16ZrusIMA-PRESS LLCНеврология, нейропсихиатрия, психосоматика2074-27112310-13422017-03-019110110510.14412/2074-2711-2017-1-101-105632The clinical features, diagnosis, and treatment of cognitive impairments in Parkinson's diseaseG. N. Akhmadeeva0R. V. Magzhanov1G. N. Tayupova2A. R. Baitimerov3Bashkir State Medical University, Ministry of Health of Russia Republic Consulting and Diagnostic Center of Extrapyramidal Pathology and Botulinum Toxin Therapy, OOO «Medstandart» National Medical HoldingBashkir State Medical University, Ministry of Health of RussiaBashkir State Medical University, Ministry of Health of Russia Republic Consulting and Diagnostic Center of Extrapyramidal Pathology and Botulinum Toxin Therapy, OOO «Medstandart» National Medical HoldingRepublic Consulting and Diagnostic Center of Extrapyramidal Pathology and Botulinum Toxin Therapy, OOO «Medstandart» National Medical HoldingThe review presents the data of recent studies dealing with cognitive impairments (CI) in patients with Parkinson's disease (PD) and gives their characteristics and epidemiology, the specific features of the pathogenesis and clinical manifestations, as well as current methods for their diagnosis and treatment. Moderate CIs (MCIs) occur in 18.9–55% of patients with PD; the prevalence of dementia during a cross-sectional study approaches 30%. The 2007 Movement Disorder Society criteria and algorithm for the diagnosis of dementia in PD and the 2012 criteria and the algorithm for the diagnosis of MCIs allow one to maximally accurately identify these disorders. Only rivastigmine is now recognized as effective in treating CI in PD and recommended for use. Overall, therapies for CI in PD have been inadequately investigated, making it necessary to conduct further large-scale studies.https://nnp.ima-press.net/nnp/article/view/706parkinson's diseasecognitive impairmentsdementia |
| spellingShingle | G. N. Akhmadeeva R. V. Magzhanov G. N. Tayupova A. R. Baitimerov The clinical features, diagnosis, and treatment of cognitive impairments in Parkinson's disease Неврология, нейропсихиатрия, психосоматика parkinson's disease cognitive impairments dementia |
| title | The clinical features, diagnosis, and treatment of cognitive impairments in Parkinson's disease |
| title_full | The clinical features, diagnosis, and treatment of cognitive impairments in Parkinson's disease |
| title_fullStr | The clinical features, diagnosis, and treatment of cognitive impairments in Parkinson's disease |
| title_full_unstemmed | The clinical features, diagnosis, and treatment of cognitive impairments in Parkinson's disease |
| title_short | The clinical features, diagnosis, and treatment of cognitive impairments in Parkinson's disease |
| title_sort | clinical features diagnosis and treatment of cognitive impairments in parkinson s disease |
| topic | parkinson's disease cognitive impairments dementia |
| url | https://nnp.ima-press.net/nnp/article/view/706 |
| work_keys_str_mv | AT gnakhmadeeva theclinicalfeaturesdiagnosisandtreatmentofcognitiveimpairmentsinparkinsonsdisease AT rvmagzhanov theclinicalfeaturesdiagnosisandtreatmentofcognitiveimpairmentsinparkinsonsdisease AT gntayupova theclinicalfeaturesdiagnosisandtreatmentofcognitiveimpairmentsinparkinsonsdisease AT arbaitimerov theclinicalfeaturesdiagnosisandtreatmentofcognitiveimpairmentsinparkinsonsdisease AT gnakhmadeeva clinicalfeaturesdiagnosisandtreatmentofcognitiveimpairmentsinparkinsonsdisease AT rvmagzhanov clinicalfeaturesdiagnosisandtreatmentofcognitiveimpairmentsinparkinsonsdisease AT gntayupova clinicalfeaturesdiagnosisandtreatmentofcognitiveimpairmentsinparkinsonsdisease AT arbaitimerov clinicalfeaturesdiagnosisandtreatmentofcognitiveimpairmentsinparkinsonsdisease |